Skip to main content
Chison Medical Technologies Co.,Ltd. logo

Chison Medical Technologies Co.,Ltd. — Investor Relations & Filings

Ticker · 688358 ISIN · CNE1000076R4 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 686 across all filing types
Latest filing 2024-04-18 Interim / Quarterly Rep…
Country CN China
Listing Shanghai Stock Exchange 688358

About Chison Medical Technologies Co.,Ltd.

https://www.chison.com/

Chison Medical Technologies Co.,Ltd. specializes in the research, development, and manufacturing of diagnostic ultrasound systems. The company offers a comprehensive portfolio of medical imaging solutions, including trolley-based color Doppler systems, portable ultrasound units, and specialized handheld devices. Its products integrate advanced imaging technologies such as 4D imaging, artificial intelligence-assisted diagnostics, and high-resolution transducers to support clinical applications in cardiology, obstetrics, gynecology, and point-of-care settings. Chison focuses on delivering high-performance diagnostic tools to healthcare providers, supported by a global network of research centers and distribution channels. The company emphasizes continuous innovation in digital signal processing and transducer technology to enhance diagnostic accuracy and clinical workflow efficiency.

Recent filings

Filing Released Lang Actions
无锡祥生医疗科技股份有限公司2024年第一季度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled '2024 年第一季度报告' which translates to '2024 First Quarter Report'. It contains detailed financial data including balance sheets, profit and loss statements, cash flow statements, and notes on financial performance for the first quarter of 2024. The report explicitly states it is unaudited and covers the period January to March 2024. The content includes comprehensive financial metrics and analysis typical of an interim or quarterly financial report. There is no indication that this is merely an announcement or a certification. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). Q1 2024
2024-04-18 Chinese
祥生医疗2023年度独立董事述职报告（徐志翰）
Board/Management Information Classification · 95% confidence The document is titled as an "Independent Director's Annual Report" for the year 2023 of Wuxi Xiangsheng Medical Technology Co., Ltd. It details the independent director's background, attendance at board meetings, communication with auditors, oversight of company operations, and compliance with laws and regulations. The content focuses on the independent director's duties, observations, and evaluations of the company's governance and operations during the year. It is not a full annual report, audit report, or financial statement, but rather a specific report by an independent director on their performance and oversight. This type of document fits best under the category of Board/Management Information (MANG), which includes announcements or reports related to board members and senior management activities. The document length (4723 characters) and detailed content support this classification rather than a brief announcement or a full financial report.
2024-04-18 Chinese
祥生医疗关于使用部分暂时闲置募集资金及自有资金进行现金管理的公告
Capital/Financing Update Classification · 95% confidence The document is an official announcement from Wuxi Xiangsheng Medical Technology Co., Ltd. regarding the use of temporarily idle raised funds and own funds for cash management. It details the board meeting resolutions, investment purpose, investment products, risk control measures, and includes independent directors' and supervisory board opinions as well as the sponsor's verification opinion. The document references regulatory guidelines on the management and use of raised funds and discloses the company's compliance with these rules. It does not contain financial statements or detailed financial performance data but rather is a regulatory disclosure about the company's cash management activities involving raised funds. This fits the category of a Capital/Financing Update (CAP) as it relates to the management and use of capital raised through fundraising activities and the company's financing management.
2024-04-18 Chinese
祥生医疗2023年度业绩快报公告
Earnings Release Classification · 95% confidence The document is titled as a '2023年度业绩快报公告' which translates to '2023 Annual Performance Express Report Announcement'. It contains preliminary financial data for the year 2023, including revenue, profit, and other key financial metrics. The data is explicitly stated as preliminary and unaudited, with a note that the final audited data will be in the 2023 Annual Report. The document is relatively short (1514 characters) and serves as a quick earnings update rather than a full comprehensive report. This matches the characteristics of an Earnings Release (ER), which is an initial announcement of quarterly or annual financial results with key highlights only. It is not a full Annual Report (10-K) or Interim Report (IR) because it lacks detailed financial statements and is preliminary. Therefore, the correct classification is Earnings Release (ER). FY 2023
2024-02-25 Chinese
祥生医疗股东减持计划完成暨减持结果公告
Major Shareholding Notification Classification · 95% confidence The document is a formal announcement from Wuxi Xiangsheng Medical Technology Co., Ltd. regarding the completion and results of a shareholder share reduction plan. It details the shareholders involved, the number of shares held before and after the reduction, the reduction period, methods, prices, and compliance with regulations. The content focuses on shareholding changes by major shareholders and related disclosures. There is no financial report, earnings data, or management discussion. The document is a notification of shareholding changes due to reduction (selling) of shares by shareholders, which fits the category of Major Shareholding Notification (MRQ). The document length is short (2165 characters), and it is not an announcement of a report publication but a substantive disclosure of shareholding changes.
2023-11-24 Chinese
祥生医疗2023年第三次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a formal announcement of the resolutions passed at the third extraordinary general meeting of shareholders in 2023 for Wuxi Xiangsheng Medical Technology Co., Ltd. It details the meeting date, attendance, voting results, and legal compliance, including lawyer witness statements. The content focuses on the voting outcomes of specific proposals and the legality of the meeting process. It does not contain financial statements, management discussion, or detailed report data. The document is an official announcement of voting results from a shareholders' meeting, which fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is short (1586 characters), consistent with an announcement rather than a full report.
2023-11-14 Chinese

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.